LOGO
LOGO

Arbutus Biopharma Corp. (ABUS)

  • Arbutus Biopharma Q1 Total Revenue Rises To $179.1 Mln From $1.8 Mln Last Year 5/13/2026 7:41:05 AM
  • Arbutus Gains FDA Fast Track For Imdusiran Hepatitis B Treatment 4/15/2026 7:57:17 AM
  • Arbutus Biopharma: FDA Grants Fast Track Designation For Imdusiran For Treatment Of Chronic Hepatitis B 4/15/2026 7:40:30 AM
  • Arbutus Biopharma FY Net Loss/shr $0.17 Vs. Loss/shr $0.38 Last Year 3/23/2026 7:48:05 AM
  • Genevant Sciences And Arbutus Biopharma Enters Into $2.25 bln Global Settlement With Moderna 3/3/2026 4:21:19 PM
  • Older Articles
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap